Depreciation of Q32 Bio Inc. from 31 Mar 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Q32 Bio Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2017 to 31 Dec 2025.
  • Q32 Bio Inc. Depreciation for the quarter ending 31 Dec 2025 was $72,000, a 56% decline year-over-year.
  • Q32 Bio Inc. Depreciation for the twelve months ending 31 Dec 2025 was $391,000, a 20% decline year-over-year.
  • Q32 Bio Inc. annual Depreciation for 2025 was $391,000, a 20% decline from 2024.
  • Q32 Bio Inc. annual Depreciation for 2024 was $487,000, a 2.4% decline from 2023.
  • Q32 Bio Inc. annual Depreciation for 2023 was $499,000, a 61% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Q32 Bio Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $391,000 $72,000 -$92,000 -56% 01 Oct 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 $483,000 $100,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $483,000 $100,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $483,000 $119,000 -$4,000 -3.3% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $487,000 $164,000 +$92,000 +128% 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $395,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $395,000 $100,000 -$100,000 -50% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $495,000 $123,000 -$4,000 -3.2% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $499,000 $72,000 -$273,000 -79% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $772,000 $100,000 -$200,000 -67% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $972,000 $200,000 -$100,000 -33% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,072,000 $127,000 -$221,000 -64% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $1,293,000 $345,000 -$1,728,000 -83% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $3,021,000 $300,000 -$1,800,000 -86% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $4,821,000 $300,000 -$1,800,000 -86% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $6,621,000 $348,000 -$1,732,000 -83% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $8,353,000 $2,073,000 +$15,000 +0.73% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $8,338,000 $2,100,000 +$100,000 +5% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $8,238,000 $2,100,000 +$100,000 +5% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $8,138,000 $2,080,000 +$173,000 +9.1% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $7,965,000 $2,058,000 +$306,000 +17% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 $7,659,000 $2,000,000 +$300,000 +18% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $7,359,000 $2,000,000 +$400,000 +25% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $6,959,000 $1,907,000 +$641,000 +51% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $6,318,000 $1,752,000 +$1,184,000 +208% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $5,134,000 $1,700,000 +$1,400,000 +467% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $3,734,000 $1,600,000 +$1,400,000 +700% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $2,334,000 $1,266,000 +$1,045,000 +473% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $1,289,000 $568,000 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $300,000 +$100,000 +50% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $200,000 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $221,000 +$90,844 +70% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q3 2017 $200,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q1 2017 $130,156 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

Q32 Bio Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $391,000 -$96,000 -20% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $487,000 -$12,000 -2.4% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $499,000 -$794,000 -61% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $1,293,000 -$7,060,000 -85% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $8,353,000 +$388,000 +4.9% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $7,965,000 +$1,647,000 +26% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022 2021 FY
2019 $6,318,000 +$5,029,000 +390% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $1,289,000 +$605,000 +88% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $684,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.